Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K Oct 15, 2012 ANNUAL REPORT
NT 10-K Sep 27, 2012 LATE FILING NOTICE
4 Aug 24, 2012 PRIMARY DOCUMENT
3/A Aug 22, 2012 PRIMARY DOCUMENT
8-K Aug 13, 2012 CURRENT REPORT
3 Aug 6, 2012 PRIMARY DOCUMENT
3 Jul 26, 2012 PRIMARY DOCUMENT
8-K Jun 27, 2012 CURRENT REPORT
D Jun 4, 2012
10-Q May 21, 2012 QUARTERLY REPORT
NT 10-Q May 15, 2012 NOTIFICATION OF LATE FILING
EFFECT Apr 13, 2012
POS AM Mar 29, 2012 AMENDMENT
10-Q/A Mar 7, 2012 AMENDED QUARTERLY REPORT
10-Q Feb 21, 2012 QUARTERLY REPORT
NT 10-Q Feb 14, 2012 NOTIFICATION OF LATE FILING
424B3 Dec 16, 2011 PROSPECTUS
EFFECT Dec 15, 2011
CORRESP Dec 13, 2011
S-1/A Dec 8, 2011 AMENDMENT NO. 5
CORRESP Dec 7, 2011
CORRESP Nov 14, 2011
S-1/A Nov 14, 2011 AMENDMENT NO. 4
UPLOAD Nov 9, 2011
CORRESP Oct 27, 2011
← Newer Page 17 of 18 · 436 filings Older →